IRIS Biomedical is a wholly owned subsidiary of Ripple Ventures established to provide neurotechnology engineering, and manufacturing services and technology licensing to the medical device industry. Our technology platform was designed from the ground up specifically for neuromodulation and bioelectronic medical device applications with a focus on high-performance closed-loop neural sensing and stimulation. We offer a range of field-proven component designs for stimulation and sensing, continuous wireless power delivery, battery charging, data telemetry, and embedded signal processing. We are an ideal technology partner for early-stage medical device companies without the budget or expertise to invest in developing a new device from the ground up. Our experienced engineering team and in-house cleanroom Class 7 facilities allow for rapid design development as well as prototype and early-stage commercial production.
